Signet Therapeutics
About:
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Website: https://www.signetbio.com
Top Investors: Sky9 Capital, 5Y Capital, Taihill Venture, Tiantu Capital, Yael Capital Management Limited
Description:
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Total Funding Amount:
$18.6M
Headquarters Location:
Newton, Massachusetts, United States
Founded Date:
2020-01-01
Founders:
Haisheng Zhang
Number of Employees:
11-50
Last Funding Date:
2021-10-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai